Primary High-grade Neuroendocrine Carcinoma of the Esophagus

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Qing Ye(Children's Hospital of Zhejiang University), Hongyan Wu(Nanjing University of Chinese Medicine), Jun Yang(Nanjing Drum Tower Hospital), Jiong Shi(St. Joseph's Hospital and Medical Center), Ling Nie(Nanjing Drum Tower Hospital), Jieyu Chen(Nanjing Drum Tower Hospital), Lily Huang(Tulane University), Qi Sun(Fudan University), Abraham Lebenthal(Harvard University)
The American Journal of Surgical Pathology
February 16, 2013
10.1097/pas.0b013e31826d2639
Cited by 108

Related Papers

2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2021|708
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362